Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1941 of 5804
-
Can an app soothe your tummy? new IBS study says maybe
Symptom relief Recruiting nowThe aim of this study is to evaluate whether the DOMINO diet application is an effective tool in the treatment of Irritable bowel syndrome in tertiary care. Furthermore, this study aims to determine the response rate of the strict low FODMAP diet in non-responders to the DOMINO d…
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Brain blood flow monitoring during heart surgery may predict stroke risk
Knowledge-focused Recruiting nowThe aims of this study are: i) to assess cerebral autoregulation and autonomic control within the different phases of cardiac surgery with cardiopulmonary bypass; ii) to compare cerebral autoregulation measures derived via cerebral blood flow velocity estimated by transcranial Do…
Phase: NA • Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Could a seaweed supplement boost blood vessel function?
Disease control CompletedThe primary aim of the proposed investigation is to examine the hypothesis that a relatively short period of rhamnan sulfate supplementation would improve key markers of vascular dysfunction in middle-aged and older adults with at least one risk factors for cardiovascular disease…
Phase: NA • Sponsor: University of Texas at Austin • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug cocktail aims to fight Hard-to-Treat sarcomas
Disease control TerminatedMany osteosarcomas are cured with a variety of combined chemotherapy and surgery, but a significant number will still relapse.VEGF promotes an immunosuppressive microenvironment and contributes to immune checkpoint inhibitor resistance in cancer.We aimed to explore the efficacy a…
Phase: PHASE2 • Sponsor: Shanghai 6th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New fluid lens could sharpen vision after cataract surgery
Disease control OngoingThe purpose of this clinical study is to evaluate the surgical, refractive, and visual outcomes with implantation of an investigational intraocular lens (IOL).
Phase: NA • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Simple blood test could spot hidden throat cancer
Diagnosis OngoingThe researchers think that a blood test (NavDx®) may be able to identify cancer early by looking for circulating DNA from Human Papillomavirus/HPV. Circulating DNA are small pieces of genes that are released into the bloodstream. The purpose of this study is to find out whether u…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 26, 2026 19:16 UTC
-
Could a simple salt boost heart failure Patients' exercise ability?
Symptom relief Recruiting nowThe goals of this project are to determine the effectiveness of acute (2 hours after a single dose) and chronic (after 6 weeks of once-a-day dosing) KNO3 treatment (10mmol) vs. placebo on quadriceps muscle power and on aerobic exercise performance (V̇O2peak) in patients with HFrEF…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Breakthrough ear tube device could make surgery obsolete for kids
Disease control OngoingThe objective of this study is to evaluate the safety and effectiveness of the Solo+ Tympanostomy Tube Device (Solo+ TTD) for the placement of tympanostomy tubes in paediatric patients undergoing a tympanostomy procedure.
Phase: NA • Sponsor: AventaMed DAC • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a Game-Like app retrain your brain to beat depression?
Symptom relief CompletedThe purpose of this study is a preliminary evaluation of a gamified attention bias modification training (GAMBT) for reducing symptoms of depression and rumination. Individuals with elevated symptoms of depression will use the digital intervention over the course of 4 weeks. They…
Phase: NA • Sponsor: Christopher G. Beevers • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New PET tracer aims to spotlight immune cells in lung cancer
Diagnosis Recruiting nowPhase II study to evaluate the clinical potential of 68GaNOTA-anti-MMR-VHH2 for in vivo imaging of Macrophage Mannose Receptor (MMR)-expressing Macrophages by means of Positron Emission Tomography (PET) in patients with non-small cell lung cancer (NSCLC) planned for surgical rese…
Phase: PHASE2 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New scan could spot hidden tumors behind rare bone disease
Diagnosis Recruiting nowThis is a pilot study to assess the value of whole-body Al18F-NOTA-LM3 PET/CT in patients with tumor-induced osteomalacia.
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:14 UTC
-
New MRI test spots leaky bladders in chronic pain condition
Diagnosis CompletedEach participant will be asked to participate in this research study which distinguishes different types of Interstitial Cystitis/Bladder Pain Syndrome. Research studies include only people who wish to participate. The study team members will explain the study to each participant…
Sponsor: Christopher J Chermansky, MD • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
Dust mite asthma study aims to uncover how dupilumab works inside the body
Knowledge-focused OngoingThe trial involves two interventions: (i) exposure to HDM in the ACC and (ii) administration of dupilumab/placebo for dupilumab.
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood-Clotting drug trial for trauma bleeding halted early
Disease control TerminatedThis is a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group, large simple trial to investigate the efficacy and safety of a single intravenous (IV) infusion of BE1116 in subjects who have traumatic injury, with confirmed or suspected acute maj…
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Brain study aims to Fine-Tune Parkinson's treatment
Knowledge-focused Recruiting nowThis study will help us better understand how the brain works in people with Parkinson's disease (PD). PD is a brain disease that gets worse over time, and affects over 10 million people world-wide. A common treatment for PD is Deep Brain Stimulation (DBS). To improve DBS therapy…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Can an extra inhaler boost lung clearance in cystic fibrosis patients already on breakthrough drugs?
Disease control CompletedThis study will provide important mechanistic information regarding the effect of inhaled mannitol (Bronchitol) in people with cystic fibrosis (PwCF) with moderate to severe disease who are already using elexacaftor/tezacaftor/ivacaftor (E/T/I). Many patients have already discont…
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New pill may calm diabetic stomach troubles
Symptom relief CompletedThe goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help reduce the symptoms associated with diabetic gastroparesis in adult patients. The main questions it aims to answer are: * To evaluate the efficacy of CIN-102 on symptoms of gastro…
Phase: PHASE2 • Sponsor: CinDome Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Gene therapy trial aims to halt blindness from rare crystal disease
Disease control OngoingA Multicenter, Open-Label, Non-Randomized, Uncontrolled Study of VGR-R01 in Patients with Bietti Crystalline Dystrophy.
Phase: PHASE1 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
School program cuts teen tech addiction and gets them moving
Disease control CompletedExcessive engagement with digital devices among adolescents has become a significant public health concern, contributing to reduced physical activity and associated health risks. This study assessed the impact of the PROBTEC Management Program-an intervention structured around th…
Phase: NA • Sponsor: Karabuk University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug ATG-022 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis is an Open, Multi-center, Phase I Clinical Study of ATG 022 in Patients with Advanced/metastatic Solid Tumors
Phase: PHASE1 • Sponsor: Antengene Biologics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC